Skip to main content

Table 2 Maternal and fetal outcomes of study participants, ACSH and MGH, North Ethiopia 2016/17. Values are given as N, mean (SD)

From: Gestational hypertension and progression towards preeclampsia in Northern Ethiopia: prospective cohort study

Variables

GH-GH

N=199

GH-PE

N=41

Total

N=240

P

Maternal outcomes

 Proteinuria

-

13 (31.7%)

13 (5.4%)

-

 Renal impairment

-

5 (12.2%)

5 (2.1%)

-

Neurologic Disease

 Headache

-

20 (48.8%)

20 (8.3%)

-

 Blurring of Vision

-

5 (12.2%)

5 (2.1%)

-

 Abnormal body movement

-

1 (2.4%)

1 (0.4%)

-

 Thrombocytopenia

-

4 (9.8%)

4 (1.7%)

-

Liver dysfunction

 Right upper quadrant pain

-

12 (29.3 %)

12 (5.0%)

-

 Epigastric pain

-

6 (14.6%)

6 (2.5%)

-

 Liver enzyme elevation

-

7 (17.1%)

7 (2.9%)

-

 Sever hypertension

-

25 (61.0%)

25 (10.4%)

-

 APH

4 (2.0%)

10 (24.4%)

14 (5.8%)

0.24

Mode of delivery

 Vaginal delivery

162 (81.4%)

29 (70.7%)

191 (79.6%)

0.58

 Instrumental delivery

4 (2.0%)

-

4(1.7%)

0.36

 CS delivery

33 (16.6%)

12(29.3 %)

45 (18.8%)

0.81

Fetal outcomes

 Gestational at delivery in weeks

38.6(2.4)

38.0 (2.0)

-

0.56

 Birth weight in grams

3167.0(1236.2)

2917.1 (545.4)

-

0.29

 1st minute Apgar score >6

193 (97.0%)

40 (97.6%)

233 (97.1%)

0.98

 1st minute Apgar score 1-6

5 (2.5%)

1 (2.4%)

6 (2.5%)

0.98

 Admission to NICU

26 (13.1%)

5 (12.2%)

31

0.06

 Stillbirth

1

-

1

0.65

  1. APH antepartum hemorrhage, CS cesarean section, GH gestational hypertension, NICU neonatal intensive care unit, PE preeclampsia, P Pearson X2 test for categorical variables and two tailed student’s t test for continuous variables